Burgdorf - In its business year 2005/06 Ypsomed has once again succeeded in significantly surpassing its previous year’s results. Consolidated sales of the Ypsomed Group rose by 28.4% from CHF 241.8 million to CHF 310.6 million. Particularly pleasing was the strong growth in the core business with sales of pen systems and pen needles up steeply at 44.7%. Operating profit rose from last year’s figure of CHF 47.5 million to CHF 62.3 million. This pushed up earnings before interest and taxes (EBIT) by 40 percentage points from 19.7% to 20.1%. Consolidated net profit rose by 42% from last year’s CHF 39.2 million to CHF 55.6 million. Net profit per share reached CHF 4.95 per share, of which CHF 1.25 will be distributed to shareholders as a repayment of nominal value. Ypsomed invested a total of CHF 40.1 million in additional production capacity in the 2005/06 business year and created 206 new jobs. In the current business year about 150 new jobs should be added. In the 2006/07 business year Ypsomed will be further optimizing its production and expects sales to grow between 10% and 15%.
Press Releases Ypsomed Group